LUCIANO, NICOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 621
EU - Europa 281
AS - Asia 123
AF - Africa 38
Totale 1.063
Nazione #
US - Stati Uniti d'America 606
SE - Svezia 92
IT - Italia 79
CN - Cina 55
BG - Bulgaria 41
SG - Singapore 31
GB - Regno Unito 22
CI - Costa d'Avorio 18
CA - Canada 15
DE - Germania 14
FR - Francia 14
VN - Vietnam 14
IN - India 11
NG - Nigeria 10
HK - Hong Kong 9
SN - Senegal 9
FI - Finlandia 8
BE - Belgio 3
GR - Grecia 2
JP - Giappone 2
RU - Federazione Russa 2
EE - Estonia 1
EG - Egitto 1
IE - Irlanda 1
PL - Polonia 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.063
Città #
Woodbridge 116
Chandler 88
Ann Arbor 51
Houston 48
Sofia 41
Fairfield 34
Ashburn 33
Beijing 23
New York 23
Wilmington 23
Florence 22
Princeton 20
Abidjan 18
Seattle 18
Lawrence 16
Medford 15
Marseille 14
London 13
Ottawa 13
Trani 13
Cambridge 12
Des Moines 12
Dearborn 10
Lagos 10
Dakar 9
Hong Kong 9
Arezzo 7
Serra 7
Nanjing 6
Palermo 6
Bremen 5
Pune 5
Dong Ket 4
San Diego 4
Shanghai 4
Shenyang 4
Brussels 3
Hebei 3
Jiaxing 3
Lancaster 3
Los Angeles 3
Düsseldorf 2
Frankfurt am Main 2
Jinan 2
Kunming 2
Milan 2
Ogden 2
Redmond 2
Simi Valley 2
Atlanta 1
Bengaluru 1
Cairo 1
Chongqing 1
Corsico 1
Council Bluffs 1
Doncaster 1
Dublin 1
Edinburgh 1
Fujita 1
Genova 1
Guangzhou 1
Guidonia 1
Hangzhou 1
Hefei 1
Indiana 1
Izmir 1
Lachine 1
Mantova 1
Montreal 1
Ningbo 1
Norwalk 1
Phoenix 1
Piombino 1
Pisa 1
Pontedera 1
Redwood City 1
San Francisco 1
Shaoxing 1
Tallinn 1
Warsaw 1
Xian 1
Totale 819
Nome #
null 91
null 86
null 76
null 69
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 65
null 61
null 56
null 56
Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: Consensual US-SG core items definition and reliability 53
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 51
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 50
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 48
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 46
One year in review 2017: novelties in the treatment of rheumatoid arthritis 42
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 42
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases. 33
Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome 29
One year in review 2015: Sjögren's syndrome 28
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 26
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 26
Salivary Gland Ultrasonography in Sjögren's Syndrome: Clinical Usefulness and Future Perspectives 24
Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review 23
null 20
Myositis in primary Sjögren's syndrome: data from a multicentre cohort 17
Totale 1.118
Categoria #
all - tutte 3.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.527


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 13 14
2019/2020124 19 7 1 9 13 18 14 9 8 10 15 1
2020/202175 4 0 4 1 1 2 3 4 23 7 0 26
2021/2022170 0 11 2 13 32 22 5 16 8 2 9 50
2022/2023311 33 56 26 14 35 37 7 17 54 1 31 0
2023/2024126 6 12 15 2 40 25 15 7 4 0 0 0
Totale 1.118